LUPKYNIS

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Romania, United Kingdom, United States

Active ingredients

The drug LUPKYNIS contains one active pharmaceutical ingredient (API):

1 Voclosporin UNII 2PN063X6B1 - VOCLOSPORIN

Voclosporin is a calcineurin-inhibitor immunosuppressant that inhibits calcineurin in a dose-dependent manner. The immunosuppressant activity results in inhibition of lymphocyte proliferation, T-cell cytokine production, and expression of T-cell activation surface antigens. Read about Voclosporin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LUPKYNIS Soft capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AD03		L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AD Calcineurin inhibitors
Discover more medicines within L04AD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 3040681, 3041165
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1221678001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 114883
Country: FR	Base de données publique des médicaments	Identifier(s): 63205919
Country: IT	Agenzia del Farmaco	Identifier(s): 050355015
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1095544, 1096438
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69557001, W69557002
Country: US	FDA, National Drug Code	Identifier(s): 75626-001